Journal
CANCER CELL
Volume 19, Issue 4, Pages 437-440Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2011.03.020
Keywords
-
Categories
Funding
- Cancer Research UK [11566] Funding Source: Medline
- Cancer Research UK [11566] Funding Source: researchfish
Ask authors/readers for more resources
Despite the promise of the new generation of molecularly targeted drugs, intrinsic and acquired resistance is proving to be as problematic as with cytotoxic drugs. Two recent papers have identified novel ways by which non-small cell lung cancers can exhibit resistance to EGFR inhibitors and suggest new therapeutic workarounds.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
